Q4 2025 Hims & Hers Health Inc Earnings Call Transcript
Key Points
- Hims & Hers Health Inc (HIMS) achieved significant growth with over 2.5 million subscribers by the end of 2025, reflecting strong customer engagement.
- The company reported a 28% year-over-year revenue growth in Q4 2025, with full-year revenue reaching $2.35 billion, a 59% increase from the previous year.
- Hims & Hers Health Inc (HIMS) successfully expanded its offerings, including new specialties like hormone therapies and lab testing, which are expected to reach $100 million in annual revenue.
- International expansion is a key focus, with acquisitions like Zava and Livewell enhancing their presence in Europe and Canada, and the recent acquisition of Eucalyptus expected to further strengthen their global footprint.
- The company is investing heavily in technology and infrastructure, including AI and wearable technology, to enhance personalized care and improve customer experience.
- There is regulatory and legal scrutiny surrounding compounded GLP1s, which could impact the growth of the weight loss segment.
- Gross margins in Q4 2025 declined due to increased expenses related to international market expansion and new specialty launches.
- The company faces challenges in maintaining profitability in international markets, with expectations of running near breakeven in newer markets.
- There is a potential revenue headwind of approximately $65 million in Q1 2026 due to changes in shipping cadences in the weight loss business.
- The company's guidance for 2026 includes a wide range of potential outcomes, reflecting uncertainty in scaling new specialties and international operations.
Hello and thank you for standing by. My name is Tiffany, and I will be your conference operator today.
At this time, I would like to welcome everyone to the hymns and hers 4th quarter 2025 earnings call.
All lines have been placed on mute to prevent any background noise.
After the speaker's remarks, there will be a question-and-answer session.
If you would like to ask a question during that time, simply press star, then the number one on your telephone keypad.
I would now like to turn the call over to Bill Newby, head of investor relations. Bill, please go ahead.
Good afternoon everyone and welcome to the Hems and Herds Health 4th quarter and full year 2025 earnings call.
Today, after the market closed, we released this quarter's shareholder letter, a copy of which you can find on our website at investors.hms.com.
On the call with me today is Andrew Dudham, our co-founder and Chief Executive Officer, and Yemiyo Kupe, our Chief
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
